JOAN PALERMO: Open Payments
NPI 1407221435 · SEA GIRT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 74 payments from 10 companies in 2025. Trend: 2023 $623 · 2024 $1,084 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $441 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $375 |
| Otsuka America Pharmaceutical, Inc. | 18 | $338 |
| Axsome Therapeutics, Inc. | 3 | $149 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| Lundbeck LLC | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Corium, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, Jornay PM, XIFAXAN, COBENFY, FANAPT.
Industry payments across NJ — which companies pay providers there.
